Skip to main content

previous disabled Page of 2
and
  1. Article

    Saving time in the radiotherapy procedures for COVID-19 pneumonia treatment. A single-institution experience

    The use of low dose radiotherapy (LD-RT) for the treatment of COVID-19 pneumonia is supported by biological rationale for its immunomodulatory effect. Some institutions have started to treat these patients sho...

    M. Bonet, S. Vázquez, E. García, M. Visus, D. Jové in Clinical and Translational Oncology (2021)

  2. Article

    Low-dose radiation therapy: could it be a game-changer for COVID-19?

    A. Montero, M. Arenas, M. Algara in Clinical and Translational Oncology (2021)

  3. No Access

    Article

    Radiotherapy is safe in patients with implantable cardiac devices. Analysis of a systematic interrogation follow-up

    The number of patients who have a cardiac implantable electronic device (CIEDs) that undergo a course of radiotherapy is increasing due to the ageing population. The majority of clinical studies only evaluate ...

    V. López-Honrubia, V. M. Hidalgo-Olivares in Clinical and Translational Oncology (2020)

  4. No Access

    Article

    Is one brachytherapy fraction of 7 Gy similar to more fractions after external beam irradiation in postoperative endometrial carcinoma?

    To determine whether brachytherapy with a single hypofractionated dose of 7 Gy provides the similar vaginal-cuff relapses and safety profile in terms of complications compared to schedules of 2 or 3 fractions ...

    Y. Zhang, C. Ascaso, A. Herreros, J. Sánchez in Clinical and Translational Oncology (2020)

  5. No Access

    Article

    Effects of radiotherapy on plasma energy metabolites in patients with breast cancer who received neoadjuvant chemotherapy

    Neoadjuvant chemotherapy (NACT) is employed in patients with breast cancer (BC) with the aim of reducing tumor burden and improving surgical outcomes. We evaluated the levels of energy metabolites pre- and pos...

    M. Arenas, S. Fernández-Arroyo, E. Rodríguez-Tomàs in Clinical and Translational Oncology (2020)

  6. No Access

    Article

    Role of boost radiotherapy for local control of pure ductal carcinoma in situ after breast-conserving surgery: a multicenter, retrospective study of 622 patients

    To evaluate the effect of boost radiotherapy on ipsilateral breast tumor recurrence (IBTR) for ductal carcinoma in situ (DCIS) after breast-conserving surgery and whole breast radiotherapy (WBRT) with or witho...

    M. J. Cambra, F. Moreno, X. Sanz, L. Anglada in Clinical and Translational Oncology (2020)

  7. No Access

    Article

    Are there enough radiation oncologists to lead the new Spanish radiotherapy?

    Radiation oncology services in Spain are undergoing a process of technical modernization, but—in a context of increasing demand by an ageing population—it is unclear whether there are enough radiation oncologi...

    A. Rodríguez, M. Arenas, P. C. Lara in Clinical and Translational Oncology (2019)

  8. No Access

    Article

    Management of patients with implanted cardiac devices during radiotherapy: results of a Spanish survey in radiation oncology departments

    There is an increasing number of patients with cardiac implantable electronic devices (CIED), either pacemakers or defibrillators, who are receiving a course of radiotherapy. Several guidelines have been publ...

    S. Sabater, A. Montero, T. López Fernández in Clinical and Translational Oncology (2018)

  9. No Access

    Article

    Are endometrial cancer radiotherapy results age related?

    To analyze the impact of age on radiotherapy results based on cancer-specific survival (CSS), vaginal-cuff relapses (VCR) and complications analysis in 438 patients with endometrial carcinoma (EC) receiving po...

    Á. Rovirosa, K. S. Cortés, C. Ascaso, A. Glickman in Clinical and Translational Oncology (2018)

  10. Article

    Correction to: Curative radiation therapy for very elderly bladder cancer patients with localized disease

    In the original version of this article the figure captions of Figs. 1 and 2 were interchanged.

    M. Bonet, T. Bonfill, M. Nuñez, L. De Verdonces in Clinical and Translational Oncology (2018)

  11. No Access

    Article

    Curative radiation therapy for very elderly bladder cancer patients with localized disease

    To report the outcomes of a cohort of very elderly muscle-invasive bladder cancer (MIBC) patients treated with contemporary 3D-conformal radiation therapy (3D-CRT) with or without concurrent chemotherapy, afte...

    M. Bonet, T. Bonfill, M. Nuñez, L. De Verdonces in Clinical and Translational Oncology (2018)

  12. No Access

    Article

    Recommendations of the Spanish brachytherapy group (GEB) of Spanish Society of Radiation Oncology (SEOR) and the Spanish Society of Medical Physics (SEFM) for high-dose rate (HDR) non melanoma skin cancer brachytherapy

    Clinical indications of brachytherapy in non-melanoma skin cancers, description of applicators and dosimetry recommendations are described based on the literature review, clinical practice and experience of S...

    S. Rodríguez, M. Arenas, C. Gutierrez, J. Richart in Clinical and Translational Oncology (2018)

  13. No Access

    Article

    Exploring Institutional Mechanisms for Scientific Input into the Management Cycle of the National Protected Area Network of Peru: Gaps and Opportunities

    Understanding how to improve decision makers’ use of scientific information across their different scales of management is a core challenge for narrowing the gap between science and conservation practice. Here...

    M. D. López-Rodríguez, H. Castro, M. Arenas in Environmental Management (2017)

  14. No Access

    Article

    Vaginal-cuff control and toxicity results of a daily HDR brachytherapy schedule in endometrial cancer patients

    To analyze the vaginal-cuff local control (VCC) and toxicity in postoperative endometrial carcinoma patients (EC) underwent high-dose-rate brachytherapy (HDR-BT) administered daily.

    I. Ríos, A. Rovirosa, C. Ascaso, I. Valduvieco in Clinical and Translational Oncology (2016)

  15. No Access

    Article

    The position and current status of radiation therapy after primary systemic therapy in breast cancer: a national survey-based expert consensus statement

    Primary systemic therapy (PST) is changing the role of radiation therapy (RT) in breast cancer. Without randomized studies, the optimal indications for RT after PST and surgery are not clear. The present study...

    M. Arenas, Á. Montero, M. D. de las Peñas, M. Algara in Clinical and Translational Oncology (2016)

  16. Article

    Genetic consequences of habitat fragmentation during a range expansion

    We investigate the effect of habitat fragmentation on the genetic diversity of a species experiencing a range expansion. These two evolutionary processes have not been studied yet, at the same time, owing to t...

    S Mona, N Ray, M Arenas, L Excoffier in Heredity (2014)

  17. Article

    Coestimation of recombination, substitution and molecular adaptation rates by approximate Bayesian computation

    The estimation of parameters in molecular evolution may be biased when some processes are not considered. For example, the estimation of selection at the molecular level using codon-substitution models can hav...

    J S Lopes, M Arenas, D Posada, M A Beaumont in Heredity (2014)

  18. No Access

    Article

    Reduction of rectal doses by removal of gas in the rectum during vaginal cuff brachytherapy

    The goal of this work was to evaluate whether the volume reduction related to removal of gas in the rectum could be translated in lower doses to organs at risk (OAR) during vaginal cuff brachytherapy (VBT).

    S. Sabater, Mª.M. Sevillano, I. Andres, R. Berenguer in Strahlentherapie und Onkologie (2013)

  19. No Access

    Article

    Consensus on the regional lymph nodes irradiation in breast cancer

    Standard locoregional treatment of early-stage breast cancer currently consists of the conservative surgery and sentinel lymph node biopsy. In the event of positive sentinel node biopsy, an axillary level I–II...

    E. Bayo, I. Herruzo, M. Arenas, M. Algara in Clinical and Translational Oncology (2013)

  20. No Access

    Article

    Three or four fractions per week in postoperative high-dose-rate brachytherapy for endometrial carcinoma. The long-term results on vaginal relapses and toxicity

    High-dose-rate brachytherapy (HDR-BT) is an accepted part of treatment for endometrial carcinoma and is usually performed in 1–2 fractions per week using different total doses and doses per fraction. To reduce...

    I. Valduvieco, Á. Rovirosa, A. Herreros, I. Romera in Clinical and Translational Oncology (2013)

previous disabled Page of 2